Children age 3-17
Showing 1 - 25 of >10,000
Batten Disease Trial in Houston (Miglustat 100Mg Oral Capsule)
Recruiting
- Batten Disease
- Miglustat 100Mg Oral Capsule
-
Houston, TexasTexas Children Hospital
May 17, 2022
MRI Sedation Trial in Japan, United States (dexmedetomidine, propofol)
Completed
- MRI Sedation
-
Little Rock, Arkansas
- +22 more
Oct 18, 2022
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D)
Active, not recruiting
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D
-
Palo Alto, California
- +7 more
Mar 22, 2022
COVID-19 Trial in Bandung (SARS-CoV-2 subunit protein recombinant vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 subunit protein recombinant vaccine
-
Bandung, Jawa Barat, IndonesiaFaculty of Medicine Universitas Padjadjaran
Feb 13, 2023
Pneumococcal Disease Trial in United States (20vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
-
Fayetteville, Arkansas
- +41 more
May 24, 2022
Traveler's Diarrhea Trial (Rifamycin SV MMX, Placebo to Rifamycin SV-MMX)
Not yet recruiting
- Traveler's Diarrhea
- Rifamycin SV MMX
- Placebo to Rifamycin SV-MMX
- (no location specified)
Jan 26, 2023
Iron Deficiency, Anaemia in Children, Iron-Deficiency Trial in United Kingdom (Ferric Maltol)
Completed
- Iron Deficiency, Anaemia in Children
- Iron-Deficiency
- Ferric Maltol
-
Leicester, United Kingdom
- +6 more
Sep 13, 2021
Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),
Completed
- Influenza
- High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
- +4 more
-
San Diego, California
- +15 more
Mar 24, 2022
Lyme Disease Trial in United States (VLA15, Normal Saline)
Recruiting
- Lyme Disease
- VLA15
- Normal Saline
-
Guntersville, Alabama
- +24 more
Jan 19, 2023
Analgesia Trial in Copenhagen (CT001)
Completed
- Analgesia
- CT001
-
Copenhagen, Region H, DenmarkAnæstesi- og Operationsafdelingen 4013 Juliane Marie Centeret
Aug 17, 2022
Malaria Trial in Kumasi, Kisumu (RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine)
Completed
- Malaria
- RTS,S/AS01E (Full dose)
- +2 more
-
Kumasi, Ghana
- +1 more
Jan 24, 2023
Hypercholesterolemia Trial in Saint Louis (Bempedoic acid)
Recruiting
- Hypercholesterolemia
- Bempedoic acid
-
Saint Louis, MissouriWashington University School of Medicine, Division of Endocrinol
Jan 12, 2023
Crohn's Disease Trial (Certolizumab pegol, Adalimumab, Placebo)
Withdrawn
- Crohn's Disease
- Certolizumab pegol
- +2 more
- (no location specified)
Jun 17, 2021
COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for
Recruiting
- COVID-19
- 1 Nebulized inhalation for booster groups
- +23 more
-
Xiangxi, Hunan, ChinaCDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
Oct 24, 2022
Vaccine Trial in Russian Federation (Vaccine for intramuscular injection, Placebo comparator (without active ingredient) for
Active, not recruiting
- Vaccine
- Vaccine for intramuscular injection
- Placebo comparator (without active ingredient) for intramuscular injection
-
Elektrostal, Moscow, Russian Federation
- +3 more
Feb 7, 2023
Monitoring Activity And Gait In Children
Recruiting
- Child, Preschool
- +2 more
- Actigraph
-
Cambridge, MassachusettsPfizer Innovation Research, PfIRe, Lab
Oct 24, 2022
Short Bowel Syndrome Trial in Worldwide (Teduglutide 0.05mg/kg, Teduglutide 0.025 mg/kg, Standard of Care)
Completed
- Short Bowel Syndrome
- Teduglutide 0.05mg/kg
- +2 more
-
Los Angeles, California
- +26 more
May 14, 2021
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 10, 2022
Vineland II Scale of Long-term Development of Pyridoxine
Not yet recruiting
- Pyridoxine-Dependent Epilepsy
- VINELAND II
-
Angers, FranceCHU Angers
Sep 19, 2023